On March 15, 2022, John McCabe notified Oncorus, Inc. (the "Company") of his intention to resign as Chief Financial Officer and Treasurer of the Company, effective April 1, 2022, to pursue an opportunity with a private company. Mr. McCabe's resignation does not result from any disagreement with the Company on any matter relating to the Company's operations, policies and practices. In connection with Mr. McCabe's resignation, the Company and Mr. McCabe intend to enter into a Consulting Agreement (the "McCabe Agreement") pursuant to which, among other things, following April 1, 2022, Mr. McCabe will provide advisory services to the Company for a period of up to six months (the "Advisory Period").

As consideration for Mr. McCabe's advisory services, Mr. McCabe will be paid an hourly rate and his outstanding equity awards will continue to vest during the Advisory Period.